<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The Liver Imaging Reporting and Data Systems (LI-RADS) treatment response algorithm following locoregional therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The Liver Imaging Reporting and Data Systems (LI-RADS) treatment response algorithm following locoregional therapy</h1>
<div class="graphic"><div class="figure"><div class="ttl">The Liver Imaging Reporting and Data Systems (LI-RADS) treatment response algorithm following locoregional therapy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The LI-RADS treatment response algorithm is used to predict the viability of HCC after locoregional treatment (eg, ablation, embolization). It is not appropriate to assess response after systemic therapy. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf?la=en.</div><div class="graphic_footnotes">MRI: magnetic resonance imaging; LR-TR: LI-RADS treatment response; HCC: hepatocellular cancer.<br/>* Images may be inevaluable due to image degradation, poor contrast bolus, or lack of multiphasic imaging.<br/>¶ Viability criteria include nodular, masslike, or thick irregular tissue in or along the treated lesion with arterial phase contrast hyperenhancement OR washout on portal venous phase OR enhancement similar to pretreatment.<br/>Δ The criteria for LR-TR nonviable include no lesional enhancement OR treatment-specific expected enhancement patterns (eg, peripheral rim enhancement).</div><div class="graphic_reference">Adapted by permission from: Springer: Abdominal Radiology. Kielar A, Fowler KJ, Lewis S, et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY) 2018; 43:218. Copyright © 2018. <a href="https://www.springer.com/journal/261" target="_blank">https://www.springer.com/journal/261</a>.</div><div id="graphicVersion">Graphic 130552 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
